Study of a α1A Adrenoceptor Selective Antagonist Silodosin to Treat Severe Benign Prostatic Hyperplasia(BPH)
Clinical trial NCT01259531 · COMPLETED
Trial details
- NCT number
- NCT01259531
- Sponsor
- JW Pharmaceutical
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2010-12-01
- Primary completion
- 2011-09-01
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.